Abstract Library

#4252 Intra-arterial Peptide Receptor Radionuclide Therapy in a Filipino male with predominantly hepatic metastasis in a known primary pancreatic neuroendocrine tumor

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) has shown positive clinical outcomes in somatostatin receptor (SSTR) overexpressing positive well-differentiated neuroendocrine tumors in combination with somatostatin analogue therapy. A noted decreased progression-free survivability in the use of PRRT has been noted in larger lesions (>3cm).

Conference:

Presenting Author: Azarraga C

Authors: Azarraga C, Leogardo D, Bandong I, Bautista-Peñalosa P,

Keywords: neuroendocrine, PRRT, intra-arterial, bulky,

#4182 DNA damage repair genes alterations in pancreatic neuroendocrine tumor treated with Temozolomide

Introduction: Temozolomide (TMZ), a standard therapy for pancreatic neuroendocrine tumors (pNETs), is an alkylating agent causing missense mutations and triggering cell death.

Conference:

Presenting Author: Trevisani E

Authors: Trevisani E, Reni A, Torresan I, Borghesani M, Rossi A,

Keywords: DNA Damage Repair, Tumor mutational burden, Neuroendocrine, Temozolomide,

#4127 A CT-based radiomics and deep learning signature for evaluating the somatostatin receptor 2 in non-functional pancreatic neuroendocrine tumors: A multicohort, retrospective study

Introduction: The diagnosis and treatment of Non-functional Pancreatic Neuroendocrine Tumor (NF-panNET) with unlabeled or labeled somatostatin analogues necessitate high expression of the somatostatin receptor subtype 2 (SSTR2), typically identified using PET or SPECT imaging. However, the application of PET or SPECT imaging is limited due to its low spatial resolution and unavailability in all units.

Conference:

Presenting Author:

Authors: Tang W, Wenchao G, Yinli C, Jie C,

Keywords: Non-functional Pancreatic Neuroendocrine Tumor, SSTR2, Radiomics, Deep-learning, CT,

#4098 A case of functional pancreatic neuroendocrine tumor with hypercalcemia as the main manifestation

Introduction: NEN is a type of rare neoplasm originated from peptidenergic neurons and neuroendocrine cells. Even for functional neuroendocrine tumors, the hormones secreted can be temporally and spatially heterogeneous. Hypercalcemia being a rare clinical manifestation of F-pNEN.

Conference:

Presenting Author: Yingmei T

Authors: Yanping Z, Yingmei T, Jieting D,

Keywords: pancreatic neuroendocrine tumor, functional, parathyroid hormone related peptide,

#4053 Risk factors of clinically relevant pancreatic fistula after pancreaticoduodenectomy for pancreatic neuroendocrine tumors – Single-center retrospective study

Introduction: Clinically relevant pancreatic fistula (CR-POPF) significantly worsens the postoperative course after pancreaticoduodenectomy (PD).

Conference:

Presenting Author:

Authors: Gajda M, Grudzińska E, Mrowiec S,

Keywords: pancreatic neuroendocrine tumor (PNET), pancreaticoduodenectomy (PD), clinically relevant pancreatic fistula (CR-POPF),